tradingkey.logo
搜尋

DaVita Inc

DVA
添加自選
210.975USD
+1.295+0.62%
收盤 06/23, 16:00美東報價延遲15分鐘
13.54B總市值
19.29本益比TTM

DaVita Inc

210.975
+1.295+0.62%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.62%

5天

+0.95%

1月

+6.27%

6月

+83.90%

今年開始到現在

+85.70%

1年

+54.74%

關鍵數據
211.710今開
213.820最高
858.13K成交量
19.29本益比TTM
13.71本益比動
--股利TTM
1.30%換手率
209.680昨收
209.950最低
108.87M成交額
14.91本益比靜
-18.48市淨率
0.00%股息率 TTM
6.33%ROA
202.69052週最高
0.97量比
936.34M淨利潤
66.19M總股本
10.9395每股盈餘TTM
0.90Beta
635.30%ROE
101.00052週最低
1.85%振幅
26.22%毛利率
13.54B總市值
2.87回報/風險
1.96%風險率

TradingKey DaVita Inc股票評分

單位: USD 更新時間: 2026-06-23

操作建議

DaVita Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療服務供應商行業排名23/76位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為193.73。中期看,股價處於上升通道。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

DaVita Inc評分

相關信息

行業排名
23 / 76
全市場排名
100 / 4573
所屬行業
醫療服務供應商

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

7°C

過冷
過熱
看好

DaVita Inc亮點

亮點風險
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
估值高估
公司最新PE估值19.28,處於3年歷史高位
機構減倉
最新機構持股36.02M股,環比減少8.30%
華倫‧巴菲特持倉
明星投資者華倫‧巴菲特持倉,最新持倉23.75M股

分析師目標

基於 9 分析師
持有
評級
193.730
目標均價
-7.61%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

DaVita Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

DaVita Inc簡介

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
公司代碼DVA
公司DaVita Inc
CEORodriguez (Javier J)
網址https://www.davita.com/

常見問題

DaVita Inc(DVA)的當前股價是多少?

DaVita Inc(DVA)的當前股價是 210.97。

DaVita Inc 的股票代碼是什麼?

DaVita Inc的股票代碼是DVA。

DaVita Inc股票的52週最高點是多少?

DaVita Inc股票的52週最高點是202.69。

DaVita Inc股票的52週最低點是多少?

DaVita Inc股票的52週最低點是101.00。

DaVita Inc的市值是多少?

DaVita Inc的市值是13.54B。

現在DaVita Inc(DVA)的股票是買入、持有還是賣出?

根據分析師評級,DaVita Inc(DVA)的總體評級為signal_hold,目標價格為193.73。

DaVita Inc(DVA)股票的每股收益(EPS TTM)是多少

DaVita Inc(DVA)股票的每股收益(EPS TTM)是10.06。
KeyAI